Please login to the form below

Not currently logged in
Email:
Password:

Audentes

This page shows the latest Audentes news and features for those working in and with pharma, biotech and healthcare.

Audentes’ rare disease gene therapy programme delayed after third patient death

Audentes’ rare disease gene therapy programme delayed after third patient death

According to Audentes, preliminary findings show that the immediate cause of death of the third patient was gastrointestinal bleeding. ... Additionally, Audentes’ investigation into why these three patients developed progressive liver dysfunction is

Latest news

More from news
Approximately 2 fully matching, plus 2 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...
Accelerating patient recruitment in clinical trials with the Clinical Enrolment Managers (CEMs)
How Innovative Trials' global Clinical Enrolment Managers (CEMs) give clinical trial sites the local touch...